Un test sanguin mesure le nombre d'éosinophiles pour diagnostiquer l'éosinophilie.
ÉosinophilieTests sanguins
#2
Quels tests sont utilisés pour évaluer les éosinophiles ?
Les tests incluent une numération formule sanguine et des tests d'allergie.
Numération formule sanguineTests d'allergie
#3
Quels symptômes indiquent une éosinophilie ?
Des symptômes comme des éruptions cutanées, de l'asthme ou des douleurs abdominales peuvent indiquer une éosinophilie.
AsthmeÉruptions cutanées
#4
Quand consulter un médecin pour des éosinophiles élevés ?
Consultez un médecin si vous avez des symptômes persistants ou graves liés à l'éosinophilie.
SymptômesConsultation médicale
#5
Quel rôle joue l'historique médical dans le diagnostic ?
L'historique médical aide à identifier des causes sous-jacentes d'éosinophilie, comme des allergies.
Historique médicalAllergies
Symptômes
5
#1
Quels sont les symptômes d'une éosinophilie ?
Les symptômes incluent des démangeaisons, des éruptions cutanées, et des problèmes respiratoires.
DémangeaisonsProblèmes respiratoires
#2
L'éosinophilie peut-elle causer de la fièvre ?
Oui, une éosinophilie peut être associée à de la fièvre dans certains cas d'infection.
FièvreInfection
#3
Comment l'éosinophilie affecte-t-elle la peau ?
Elle peut provoquer des éruptions cutanées, des rougeurs et des démangeaisons.
Éruptions cutanéesDermatite
#4
Peut-on avoir des douleurs abdominales avec l'éosinophilie ?
Oui, des douleurs abdominales peuvent survenir, souvent liées à des infections ou allergies.
Douleurs abdominalesInfections
#5
L'éosinophilie est-elle liée à des troubles respiratoires ?
Oui, elle est souvent associée à des troubles comme l'asthme et la rhinite allergique.
AsthmeRhinite allergique
Prévention
5
#1
Comment prévenir l'éosinophilie ?
Évitez les allergènes connus et maintenez une bonne hygiène pour prévenir les infections.
AllergènesHygiène
#2
Les vaccinations aident-elles à prévenir l'éosinophilie ?
Oui, les vaccinations peuvent prévenir certaines infections qui déclenchent l'éosinophilie.
VaccinationsInfections
#3
Quel rôle joue l'alimentation dans la prévention ?
Une alimentation équilibrée renforce le système immunitaire et peut réduire les allergies.
Alimentation équilibréeSystème immunitaire
#4
Les tests allergologiques sont-ils utiles ?
Oui, ils aident à identifier les allergènes et à éviter les réactions allergiques.
Tests allergologiquesRéactions allergiques
#5
Comment gérer les allergies pour prévenir l'éosinophilie ?
Évitez les allergènes, utilisez des antihistaminiques et consultez un allergologue.
AllergiesAntihistaminiques
Traitements
5
#1
Quels traitements sont disponibles pour l'éosinophilie ?
Les traitements incluent des corticostéroïdes, des antihistaminiques et des médicaments ciblés.
CorticostéroïdesAntihistaminiques
#2
Les corticostéroïdes sont-ils efficaces contre l'éosinophilie ?
Oui, ils réduisent l'inflammation et le nombre d'éosinophiles dans le sang.
CorticostéroïdesInflammation
#3
Comment les antihistaminiques aident-ils ?
Ils soulagent les symptômes allergiques associés à l'éosinophilie, comme les démangeaisons.
AntihistaminiquesAllergies
#4
Y a-t-il des traitements spécifiques pour les infections ?
Oui, des antiparasitaires ou antibiotiques peuvent être prescrits selon l'infection.
AntiparasitairesAntibiotiques
#5
Les changements de mode de vie peuvent-ils aider ?
Oui, éviter les allergènes et adopter une alimentation saine peuvent réduire les symptômes.
AllergènesAlimentation saine
Complications
5
#1
Quelles complications peuvent survenir avec l'éosinophilie ?
Des complications incluent des troubles respiratoires, des maladies auto-immunes et des infections.
Troubles respiratoiresMaladies auto-immunes
#2
L'éosinophilie peut-elle affecter le cœur ?
Oui, elle peut entraîner des myocardites ou d'autres complications cardiaques.
MyocarditesComplications cardiaques
#3
Quels risques pour le système digestif ?
Elle peut causer des troubles gastro-intestinaux, comme des douleurs et des inflammations.
Troubles gastro-intestinauxInflammations
#4
Y a-t-il un risque de cancer lié à l'éosinophilie ?
Certaines études suggèrent un lien entre éosinophilie et cancers hématologiques.
CancerHématologie
#5
Comment l'éosinophilie affecte-t-elle la qualité de vie ?
Elle peut réduire la qualité de vie en provoquant des symptômes chroniques et des limitations.
Qualité de vieSymptômes chroniques
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque d'éosinophilie ?
Les allergies, les infections parasitaires et certaines maladies auto-immunes augmentent le risque.
AllergiesInfections parasitaires
#2
L'exposition à des allergènes augmente-t-elle le risque ?
Oui, l'exposition répétée à des allergènes peut augmenter le risque d'éosinophilie.
AllergènesExposition
#3
Les maladies auto-immunes sont-elles un facteur de risque ?
Oui, certaines maladies auto-immunes peuvent entraîner une augmentation des éosinophiles.
Maladies auto-immunesÉosinophiles
#4
Le stress peut-il influencer l'éosinophilie ?
Le stress peut exacerber les allergies et potentiellement augmenter les éosinophiles.
StressAllergies
#5
Les antécédents familiaux jouent-ils un rôle ?
Oui, des antécédents familiaux d'allergies ou d'éosinophilie peuvent augmenter le risque.
Antécédents familiauxAllergies
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Granulocytes éosinophiles : Questions médicales les plus fréquentes",
"headline": "Granulocytes éosinophiles : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Granulocytes éosinophiles : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-15",
"dateModified": "2026-05-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Granulocytes éosinophiles"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Granulocytes",
"url": "https://questionsmedicales.fr/mesh/D006098",
"about": {
"@type": "MedicalCondition",
"name": "Granulocytes",
"code": {
"@type": "MedicalCode",
"code": "D006098",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A15.382.490.315"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Granulocytes éosinophiles",
"alternateName": "Eosinophils",
"code": {
"@type": "MedicalCode",
"code": "D004804",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Marc E Rothenberg",
"url": "https://questionsmedicales.fr/author/Marc%20E%20Rothenberg",
"affiliation": {
"@type": "Organization",
"name": "From the Divisions of Allergy and Immunology (M.E.R., J.M.C.) and Pathology and Laboratory Medicine (M.H.C.), Department of Pediatrics, and the Department of Pathology and Laboratory Medicine (M.H.C.), University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati; the Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (E.S.D.); the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam (A.J.B.); the Kenneth C. Griffin Esophageal Center, Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago (I.H.); the Division of Gastroenterology, Department of Internal Medicine, University of Utah, Salt Lake City (K.A.P.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, United Kingdom (L.B.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden (H.F., H.G.); and Patient Centered Science, BioPharmaceuticals Medical Evidence (C.N.H.), Late-stage Respiratory and Immunology (M.K., C.J.D.) and Translational Science and Experimental Medicine, Early Respiratory and Immunology (C.M.), BioPharmaceuticals Research and Development, and Data Sciences and AI (D.S.) and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences (W.I.W.), Research and Development, AstraZeneca, Gaithersburg, MD."
}
},
{
"@type": "Person",
"name": "Evan S Dellon",
"url": "https://questionsmedicales.fr/author/Evan%20S%20Dellon",
"affiliation": {
"@type": "Organization",
"name": "From the Divisions of Allergy and Immunology (M.E.R., J.M.C.) and Pathology and Laboratory Medicine (M.H.C.), Department of Pediatrics, and the Department of Pathology and Laboratory Medicine (M.H.C.), University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati; the Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (E.S.D.); the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam (A.J.B.); the Kenneth C. Griffin Esophageal Center, Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago (I.H.); the Division of Gastroenterology, Department of Internal Medicine, University of Utah, Salt Lake City (K.A.P.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, United Kingdom (L.B.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden (H.F., H.G.); and Patient Centered Science, BioPharmaceuticals Medical Evidence (C.N.H.), Late-stage Respiratory and Immunology (M.K., C.J.D.) and Translational Science and Experimental Medicine, Early Respiratory and Immunology (C.M.), BioPharmaceuticals Research and Development, and Data Sciences and AI (D.S.) and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences (W.I.W.), Research and Development, AstraZeneca, Gaithersburg, MD."
}
},
{
"@type": "Person",
"name": "Margaret H Collins",
"url": "https://questionsmedicales.fr/author/Margaret%20H%20Collins",
"affiliation": {
"@type": "Organization",
"name": "From the Divisions of Allergy and Immunology (M.E.R., J.M.C.) and Pathology and Laboratory Medicine (M.H.C.), Department of Pediatrics, and the Department of Pathology and Laboratory Medicine (M.H.C.), University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati; the Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (E.S.D.); the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam (A.J.B.); the Kenneth C. Griffin Esophageal Center, Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago (I.H.); the Division of Gastroenterology, Department of Internal Medicine, University of Utah, Salt Lake City (K.A.P.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, United Kingdom (L.B.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden (H.F., H.G.); and Patient Centered Science, BioPharmaceuticals Medical Evidence (C.N.H.), Late-stage Respiratory and Immunology (M.K., C.J.D.) and Translational Science and Experimental Medicine, Early Respiratory and Immunology (C.M.), BioPharmaceuticals Research and Development, and Data Sciences and AI (D.S.) and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences (W.I.W.), Research and Development, AstraZeneca, Gaithersburg, MD."
}
},
{
"@type": "Person",
"name": "Guang-Yu Yang",
"url": "https://questionsmedicales.fr/author/Guang-Yu%20Yang",
"affiliation": {
"@type": "Organization",
"name": "the Division of Gastrointestinal Pathology, Department of Pathology, Fineberg School of Medicine, Northwestern University, Chicago, IL."
}
},
{
"@type": "Person",
"name": "Hirohito Kita",
"url": "https://questionsmedicales.fr/author/Hirohito%20Kita",
"affiliation": {
"@type": "Organization",
"name": "Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic, 13400 E Shea Blvd., Scottsdale, AZ, 85259, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The Tissue Lymphocyte-to-Eosinophil Ratio Predicted Long-Term Recurrence of Eosinophilic CRSwNP.",
"datePublished": "2023-06-04",
"url": "https://questionsmedicales.fr/article/37271971",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/19458924231179615"
}
},
{
"@type": "ScholarlyArticle",
"name": "Eosinophils in metastatic melanoma.",
"datePublished": "2023-08-12",
"url": "https://questionsmedicales.fr/article/37574050",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.humpath.2023.08.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Predictive Value of Eosinophil Cationic Protein in Nasal Secretions in Eosinophilic Chronic Rhinosinusitis.",
"datePublished": "2023-05-31",
"url": "https://questionsmedicales.fr/article/37255052",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/lary.30692"
}
},
{
"@type": "ScholarlyArticle",
"name": "Inflammatory profile of eosinophils in asthma-COPD overlap and eosinophilic COPD: a multi-omics study.",
"datePublished": "2024-10-08",
"url": "https://questionsmedicales.fr/article/39439801",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2024.1445769"
}
},
{
"@type": "ScholarlyArticle",
"name": "Engineering bispecific T-cell engagers to deplete eosinophils for the treatment of severe eosinophilic asthma.",
"datePublished": "2023-09-09",
"url": "https://questionsmedicales.fr/article/37673224",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clim.2023.109755"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Systèmes sanguin et immunitaire",
"item": "https://questionsmedicales.fr/mesh/D006424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007107"
},
{
"@type": "ListItem",
"position": 4,
"name": "Leucocytes",
"item": "https://questionsmedicales.fr/mesh/D007962"
},
{
"@type": "ListItem",
"position": 5,
"name": "Granulocytes",
"item": "https://questionsmedicales.fr/mesh/D006098"
},
{
"@type": "ListItem",
"position": 6,
"name": "Granulocytes éosinophiles",
"item": "https://questionsmedicales.fr/mesh/D004804"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Granulocytes éosinophiles - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Granulocytes éosinophiles",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Granulocytes éosinophiles",
"description": "Comment diagnostiquer une éosinophilie ?\nQuels tests sont utilisés pour évaluer les éosinophiles ?\nQuels symptômes indiquent une éosinophilie ?\nQuand consulter un médecin pour des éosinophiles élevés ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D004804#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Granulocytes éosinophiles",
"description": "Quels sont les symptômes d'une éosinophilie ?\nL'éosinophilie peut-elle causer de la fièvre ?\nComment l'éosinophilie affecte-t-elle la peau ?\nPeut-on avoir des douleurs abdominales avec l'éosinophilie ?\nL'éosinophilie est-elle liée à des troubles respiratoires ?",
"url": "https://questionsmedicales.fr/mesh/D004804#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Granulocytes éosinophiles",
"description": "Comment prévenir l'éosinophilie ?\nLes vaccinations aident-elles à prévenir l'éosinophilie ?\nQuel rôle joue l'alimentation dans la prévention ?\nLes tests allergologiques sont-ils utiles ?\nComment gérer les allergies pour prévenir l'éosinophilie ?",
"url": "https://questionsmedicales.fr/mesh/D004804#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Granulocytes éosinophiles",
"description": "Quels traitements sont disponibles pour l'éosinophilie ?\nLes corticostéroïdes sont-ils efficaces contre l'éosinophilie ?\nComment les antihistaminiques aident-ils ?\nY a-t-il des traitements spécifiques pour les infections ?\nLes changements de mode de vie peuvent-ils aider ?",
"url": "https://questionsmedicales.fr/mesh/D004804#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Granulocytes éosinophiles",
"description": "Quelles complications peuvent survenir avec l'éosinophilie ?\nL'éosinophilie peut-elle affecter le cœur ?\nQuels risques pour le système digestif ?\nY a-t-il un risque de cancer lié à l'éosinophilie ?\nComment l'éosinophilie affecte-t-elle la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D004804#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Granulocytes éosinophiles",
"description": "Quels sont les principaux facteurs de risque d'éosinophilie ?\nL'exposition à des allergènes augmente-t-elle le risque ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nLe stress peut-il influencer l'éosinophilie ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D004804#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une éosinophilie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test sanguin mesure le nombre d'éosinophiles pour diagnostiquer l'éosinophilie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les éosinophiles ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent une numération formule sanguine et des tests d'allergie."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une éosinophilie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des éruptions cutanées, de l'asthme ou des douleurs abdominales peuvent indiquer une éosinophilie."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin pour des éosinophiles élevés ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin si vous avez des symptômes persistants ou graves liés à l'éosinophilie."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier des causes sous-jacentes d'éosinophilie, comme des allergies."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une éosinophilie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des démangeaisons, des éruptions cutanées, et des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "L'éosinophilie peut-elle causer de la fièvre ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une éosinophilie peut être associée à de la fièvre dans certains cas d'infection."
}
},
{
"@type": "Question",
"name": "Comment l'éosinophilie affecte-t-elle la peau ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer des éruptions cutanées, des rougeurs et des démangeaisons."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des douleurs abdominales avec l'éosinophilie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs abdominales peuvent survenir, souvent liées à des infections ou allergies."
}
},
{
"@type": "Question",
"name": "L'éosinophilie est-elle liée à des troubles respiratoires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est souvent associée à des troubles comme l'asthme et la rhinite allergique."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'éosinophilie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les allergènes connus et maintenez une bonne hygiène pour prévenir les infections."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles à prévenir l'éosinophilie ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent prévenir certaines infections qui déclenchent l'éosinophilie."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'alimentation dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée renforce le système immunitaire et peut réduire les allergies."
}
},
{
"@type": "Question",
"name": "Les tests allergologiques sont-ils utiles ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils aident à identifier les allergènes et à éviter les réactions allergiques."
}
},
{
"@type": "Question",
"name": "Comment gérer les allergies pour prévenir l'éosinophilie ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les allergènes, utilisez des antihistaminiques et consultez un allergologue."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour l'éosinophilie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des corticostéroïdes, des antihistaminiques et des médicaments ciblés."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils efficaces contre l'éosinophilie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils réduisent l'inflammation et le nombre d'éosinophiles dans le sang."
}
},
{
"@type": "Question",
"name": "Comment les antihistaminiques aident-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils soulagent les symptômes allergiques associés à l'éosinophilie, comme les démangeaisons."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements spécifiques pour les infections ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antiparasitaires ou antibiotiques peuvent être prescrits selon l'infection."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie peuvent-ils aider ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les allergènes et adopter une alimentation saine peuvent réduire les symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'éosinophilie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles respiratoires, des maladies auto-immunes et des infections."
}
},
{
"@type": "Question",
"name": "L'éosinophilie peut-elle affecter le cœur ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des myocardites ou d'autres complications cardiaques."
}
},
{
"@type": "Question",
"name": "Quels risques pour le système digestif ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut causer des troubles gastro-intestinaux, comme des douleurs et des inflammations."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de cancer lié à l'éosinophilie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre éosinophilie et cancers hématologiques."
}
},
{
"@type": "Question",
"name": "Comment l'éosinophilie affecte-t-elle la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut réduire la qualité de vie en provoquant des symptômes chroniques et des limitations."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'éosinophilie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les allergies, les infections parasitaires et certaines maladies auto-immunes augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'exposition à des allergènes augmente-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition répétée à des allergènes peut augmenter le risque d'éosinophilie."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent entraîner une augmentation des éosinophiles."
}
},
{
"@type": "Question",
"name": "Le stress peut-il influencer l'éosinophilie ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut exacerber les allergies et potentiellement augmenter les éosinophiles."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux d'allergies ou d'éosinophilie peuvent augmenter le risque."
}
}
]
}
]
}
From the Divisions of Allergy and Immunology (M.E.R., J.M.C.) and Pathology and Laboratory Medicine (M.H.C.), Department of Pediatrics, and the Department of Pathology and Laboratory Medicine (M.H.C.), University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati; the Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (E.S.D.); the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam (A.J.B.); the Kenneth C. Griffin Esophageal Center, Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago (I.H.); the Division of Gastroenterology, Department of Internal Medicine, University of Utah, Salt Lake City (K.A.P.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, United Kingdom (L.B.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden (H.F., H.G.); and Patient Centered Science, BioPharmaceuticals Medical Evidence (C.N.H.), Late-stage Respiratory and Immunology (M.K., C.J.D.) and Translational Science and Experimental Medicine, Early Respiratory and Immunology (C.M.), BioPharmaceuticals Research and Development, and Data Sciences and AI (D.S.) and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences (W.I.W.), Research and Development, AstraZeneca, Gaithersburg, MD.
From the Divisions of Allergy and Immunology (M.E.R., J.M.C.) and Pathology and Laboratory Medicine (M.H.C.), Department of Pediatrics, and the Department of Pathology and Laboratory Medicine (M.H.C.), University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati; the Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (E.S.D.); the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam (A.J.B.); the Kenneth C. Griffin Esophageal Center, Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago (I.H.); the Division of Gastroenterology, Department of Internal Medicine, University of Utah, Salt Lake City (K.A.P.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, United Kingdom (L.B.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden (H.F., H.G.); and Patient Centered Science, BioPharmaceuticals Medical Evidence (C.N.H.), Late-stage Respiratory and Immunology (M.K., C.J.D.) and Translational Science and Experimental Medicine, Early Respiratory and Immunology (C.M.), BioPharmaceuticals Research and Development, and Data Sciences and AI (D.S.) and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences (W.I.W.), Research and Development, AstraZeneca, Gaithersburg, MD.
From the Divisions of Allergy and Immunology (M.E.R., J.M.C.) and Pathology and Laboratory Medicine (M.H.C.), Department of Pediatrics, and the Department of Pathology and Laboratory Medicine (M.H.C.), University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati; the Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (E.S.D.); the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam (A.J.B.); the Kenneth C. Griffin Esophageal Center, Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago (I.H.); the Division of Gastroenterology, Department of Internal Medicine, University of Utah, Salt Lake City (K.A.P.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, United Kingdom (L.B.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden (H.F., H.G.); and Patient Centered Science, BioPharmaceuticals Medical Evidence (C.N.H.), Late-stage Respiratory and Immunology (M.K., C.J.D.) and Translational Science and Experimental Medicine, Early Respiratory and Immunology (C.M.), BioPharmaceuticals Research and Development, and Data Sciences and AI (D.S.) and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences (W.I.W.), Research and Development, AstraZeneca, Gaithersburg, MD.
From the Divisions of Allergy and Immunology (M.E.R., J.M.C.) and Pathology and Laboratory Medicine (M.H.C.), Department of Pediatrics, and the Department of Pathology and Laboratory Medicine (M.H.C.), University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati; the Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (E.S.D.); the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam (A.J.B.); the Kenneth C. Griffin Esophageal Center, Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago (I.H.); the Division of Gastroenterology, Department of Internal Medicine, University of Utah, Salt Lake City (K.A.P.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, United Kingdom (L.B.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden (H.F., H.G.); and Patient Centered Science, BioPharmaceuticals Medical Evidence (C.N.H.), Late-stage Respiratory and Immunology (M.K., C.J.D.) and Translational Science and Experimental Medicine, Early Respiratory and Immunology (C.M.), BioPharmaceuticals Research and Development, and Data Sciences and AI (D.S.) and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences (W.I.W.), Research and Development, AstraZeneca, Gaithersburg, MD.
the Division of Pediatric Gastroenterology, Hepatology and Nutrition, Riley Hospital for Children/Indiana University School of Medicine, and Community Health Network, Indianapolis, IN.
the Department of Pediatrics, Cincinnati Children's Hospital and the University of Cincinnati College of Medicine, Cincinnati, OH.
the Division of Human Genetics, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and the University of Cincinnati, Cincinnati, OH.
the Division of Gastroenterology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and the University of Cincinnati, Cincinnati, OH.
Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic, 13400 E Shea Blvd., Scottsdale, AZ, 85259, USA. wright.benjamin@mayo.edu.
Division of Pulmonology, Department of Pediatrics, Phoenix Children's Hospital, 1919 E Thomas Rd, Phoenix, AZ, 85016, USA. wright.benjamin@mayo.edu.
Eosinophilic chronic rhinosinusitis with nasal polyps (Eos-CRSwNP) remains a recalcitrant disease with a high recurrence rate....
This study aimed to identify a predictor of long-term recurrence in patients with Eos-CRSwNP....
A total of 39 Eos-CRSwNP patients who had their initial and recurrent nasal polyps surgically removed were retrospectively included in this study, with 49 Eos-CRSwNP patients without recurrence and 32...
The number and ratio of tissue eosinophils were highest in Eos-CRSwNP with recurrence and lowest in non-Eos-CRSwNP. The ratio of tissue lymphocytes was highest in non-Eos-CRSwNP and lowest in Eos-CRSw...
Tissue LER is strongly associated with Eos-CRSwNP recurrence and may play a key role in predicting long-term Eos-CRSwNP recurrence....
The potential significance of tissue eosinophils melanomas is unknown. We strove to determine a potential association between the presence of tissue eosinophils and prognosis of patients with metastat...
To investigate the value of secretions Eosinophilic cationic protein (ECP) detection in the diagnosis of endotypes of Chronic rhinosinusitis (CRS) and its correlation with clinical symptoms, so as to ...
Patients' nasal secretions and polyps (or middle turbinate for control) were collected and their EOS% and ECP levels were measured. Correlation analysis was performed for EOS% and ECP levels in secret...
Eosinophilic chronic rhinosinusitis (ECRS) patients had higher concentrations of ECP in nasal secretions than healthy subjects and NECRS (non-eosinophilic CRS) (p < 0.0001;0.0001); EOS% in nasal secre...
Measurement of ECP in nasal secretions is useful for non-invasive diagnosis of ECRS....
3 Laryngoscope, 133:3304-3312, 2023....
Elevated blood eosinophil levels in patients with chronic obstructive pulmonary disease (COPD) with or without asthma are linked to increased exacerbations and the effectiveness of inhaled corticoster...
Eosinophils were isolated from the peripheral blood of healthy volunteers, patients with non-eCOPD, and those with ACO/eCOPD. Multi-omics analysis involving transcriptomics, proteomics, and lipidomics...
Proteomics and transcriptomics analyses revealed cellular characteristics in overall COPD patients represented by viral infection (elevated expression of sterol regulatory element-binding protein-1) a...
ACO/eCOPD is associated with viral infection and an inflammatory milieu. Therapeutic strategies using statins and inhaled corticosteroids are recommended to control these pathogenic changes....
Severe eosinophilic asthma (SEA) is characterized by elevated eosinophil counts in the blood and airway mucosa. While monoclonal antibody therapies targeting interleukin-5 (IL-5) and its receptor (IL-...
Over the past years, eosinophils have become a focus of scientific interest, especially in the context of their recently uncovered functions (e.g. antiviral, anti-inflammatory, regulatory). These vers...
Eosinophils are typically considered tissue-damaging effector cells in type 2 immune-related diseases. However, they are also increasingly recognized as important modulators of various homeostatic pro...
Eosinophils are often encountered in the stroma and peritumoral microenvironment of squamous cell carcinomas. Because eosinophils are readily identified on routine hematoxylin and eosin stained sectio...
Bullous pemphigoid (BP) is an autoimmune blistering skin disease, of which the incidence has increased in recent years. BP is characterized by circulating IgG and IgE autoantibodies against the hemide...
The ability of human tissue to reorganize and restore its existing structure underlies tissue homeostasis in the healthy airways, but in disease can persist without normal resolution, leading to an al...